Clinical, PHE and NICE Guideline support

COVID-19 Trusted Evidence 

The Centre for Evidence-Based Medicine (CEBM) have established the Oxford COVID-19 Evidence Service and we are also supporting the COVID-19 RCGP Scientific Steering Committee.

These rapid systematic review services have gained rapid adoption with over 2 million views for the Evidence Service in its first 10 days, and had in excess of 70 reviews developed an published during April alone.

The Evidence Service is now recognised as having ‘a lasting research value’ by the Oxford University Bodleian Library and worthy of permanent preservation in their web archive.

Further Information:

www.cebm.net/covid-19

COVID-19 and cystic fibrosis rapid guideline
(NG170)

Further information:

www.nice.org.uk/guidance/ng170

Professors Richard Hobbs, Trisha Greenhalgh and Carl Henegan also played a key role in developing rapid NICE guidance on managing suspected or confirmed pneumonia in adults in the community during the COVID-19 pandemic.

Further information:

www.nice.org.uk/guidance/ng165/chapter/2-Treatment-and-care-planning

Bethan McDonald, ARC Partner Manager and public health specialist, is supporting the Thames Valley Public Health England health protection team in its response.

This involves providing public health advice, guidance and management support to providers across the Thames Valley. We are working mainly with primary care, secondary care, laboratories, care homes, prisons, schools and local authorities – providing risk assessments of outbreaks and guidance on control and management. 

Further information: 

www.gov.uk/government/organisations/public-health-england